Arrowgrass Capital Partners (US)’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-885,401
| Closed | -$16.8M | – | 259 |
|
|
2017
Q4 | $16.8M | Buy |
885,401
+36,489
| +4% | +$691K | 0.16% | 56 |
|
|
2017
Q3 | $14.9M | Buy |
848,912
+439,509
| +107% | +$7.74M | 0.11% | 93 |
|
|
2017
Q2 | $13.6M | Buy |
409,403
+8,195
| +2% | +$272K | 0.1% | 107 |
|
|
2017
Q1 | $12.9M | Buy |
+401,208
| New | +$12.9M | 0.13% | 87 |
|
|
2016
Q2 | – | Sell |
-100,000
| Closed | -$5.35M | – | 242 |
|
|
2016
Q1 | $5.35M | Buy |
+100,000
| New | +$5.35M | 0.06% | 95 |
|